MAFD9
MCID: MJR024
MIFTS: 41

Major Affective Disorder 9 (MAFD9)

Categories: Genetic diseases, Mental diseases

Aliases & Classifications for Major Affective Disorder 9

MalaCards integrated aliases for Major Affective Disorder 9:

Name: Major Affective Disorder 9 56 13 71
Major Affective Disorder-9, Susceptibility to 56
Bipolar Affective Disorder 56
Major Affective Disorder-9 56
Bipolar Disorder 71
Mafd9 56

Classifications:



External Ids:

OMIM 56 612372
MedGen 41 C2700440
UMLS 71 C0005586 C2700440

Summaries for Major Affective Disorder 9

MalaCards based summary : Major Affective Disorder 9, also known as major affective disorder-9, susceptibility to, is related to major affective disorder 1 and bipolar disorder. An important gene associated with Major Affective Disorder 9 is MAFD9 (Major Affective Disorder-9, Susceptibility To). The drugs Eleuthero and Reboxetine have been mentioned in the context of this disorder. Affiliated tissues include brain, cortex and testes.

More information from OMIM: 612372

Related Diseases for Major Affective Disorder 9

Diseases in the Major Affective Disorder 1 family:

Major Affective Disorder 2 Major Affective Disorder 3
Major Affective Disorder 4 Major Affective Disorder 5
Major Affective Disorder 6 Major Affective Disorder 8
Major Affective Disorder 7 Major Affective Disorder 9

Diseases related to Major Affective Disorder 9 via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 184)
# Related Disease Score Top Affiliating Genes
1 major affective disorder 1 12.5
2 bipolar disorder 12.3
3 major affective disorder 5 12.0
4 major affective disorder 6 12.0
5 major affective disorder 2 12.0
6 major affective disorder 8 11.9
7 major affective disorder 3 11.6
8 major affective disorder 4 11.6
9 major affective disorder 7 11.6
10 mood disorder 10.7
11 endogenous depression 10.5
12 schizophrenia 10.5
13 depression 10.5
14 mental depression 10.5
15 bipolar i disorder 10.4
16 major depressive disorder 10.4
17 personality disorder 10.3
18 psychotic disorder 10.3
19 schizoaffective disorder 10.3
20 alcohol dependence 10.3
21 tardive dyskinesia 10.3
22 obsessive-compulsive disorder 10.3
23 hypothyroidism 10.2
24 substance abuse 10.2
25 cyclothymic disorder 10.2
26 huntington disease 10.1
27 attention deficit-hyperactivity disorder 10.1
28 mental health wellness 1 10.1
29 mental health wellness 2 10.1
30 severe combined immunodeficiency 10.1
31 multiple sclerosis 10.1
32 autism 10.1
33 thalassemia 10.1
34 hydrocephalus 10.1
35 borderline personality disorder 10.1
36 avoidant personality disorder 10.1
37 adenoma 10.1
38 head injury 10.1
39 schizophrenia 1 10.0
40 frontotemporal dementia 10.0
41 anxiety 10.0
42 alacrima, achalasia, and mental retardation syndrome 10.0
43 exanthem 10.0
44 physical disorder 10.0
45 dementia 10.0
46 alcohol use disorder 10.0
47 movement disease 10.0
48 panic disorder 10.0
49 hyperthyroidism 10.0
50 learning disability 10.0

Comorbidity relations with Major Affective Disorder 9 via Phenotypic Disease Network (PDN):


Acute Cystitis Bipolar Disorder
Deficiency Anemia Heart Disease
Hypertension, Essential Hypothyroidism
Major Depressive Disorder Parkinson Disease, Late-Onset
Schizophreniform Disorder

Graphical network of the top 20 diseases related to Major Affective Disorder 9:



Diseases related to Major Affective Disorder 9

Symptoms & Phenotypes for Major Affective Disorder 9

Clinical features from OMIM:

612372

Drugs & Therapeutics for Major Affective Disorder 9

Drugs for Major Affective Disorder 9 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 439)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Eleuthero Approved, Experimental Phase 4
2
Reboxetine Approved, Experimental Phase 4 71620-89-8, 98769-81-4 123628 65856
3
Risperidone Approved, Investigational Phase 4 106266-06-2 5073
4
Galantamine Approved Phase 4 357-70-0 9651
5
Ropinirole Approved, Investigational Phase 4 91374-20-8, 91374-21-9 5095 497540
6
Memantine Approved, Investigational Phase 4 19982-08-2 4054
7
Topiramate Approved Phase 4 97240-79-4 5284627
8
Tranylcypromine Approved, Investigational Phase 4 155-09-9 441233
9
Naltrexone Approved, Investigational, Vet_approved Phase 4 16590-41-3 5360515
10
Cocaine Approved, Illicit Phase 4 50-36-2 5760 446220
11
Paroxetine Approved, Investigational Phase 4 61869-08-7 43815
12
Acamprosate Approved, Investigational Phase 4 77337-76-9 71158
13
Levetiracetam Approved Phase 4 102767-28-2 441341
14
Minocycline Approved, Investigational Phase 4 10118-90-8 5281021
15
Celecoxib Approved, Investigational Phase 4 169590-42-5 2662
16
Nicotinamide Approved, Investigational Phase 4 98-92-0 936
17
Cycloserine Approved Phase 4 68-41-7 401 6234
18
Norepinephrine Approved Phase 4 51-41-2 439260
19
Sertraline Approved Phase 4 79617-96-2 68617
20
Nortriptyline Approved Phase 4 72-69-5 4543
21
Exenatide Approved, Investigational Phase 4 141758-74-9 15991534
22
Acetylcholine Approved, Investigational Phase 4 51-84-3 187
23
Mirtazapine Approved Phase 4 85650-52-8, 61337-67-5 4205
24
Histamine Approved, Investigational Phase 4 51-45-6 774
25
Iloperidone Approved Phase 4 133454-47-4 71360
26
Brexpiprazole Approved, Investigational Phase 4 913611-97-9 11978813
27
Methohexital Approved Phase 4 151-83-7 9034
28
Dipyridamole Approved Phase 4 58-32-2 3108
29
Chlorpromazine Approved, Investigational, Vet_approved Phase 4 50-53-3 2726
30
Phenytoin Approved, Vet_approved Phase 4 57-41-0 1775
31
Acetylcysteine Approved, Investigational Phase 4 616-91-1 12035
32
Carbamazepine Approved, Investigational Phase 4 298-46-4 2554
33
Varenicline Approved, Investigational Phase 4 249296-44-4 5310966
34
Methylphenidate Approved, Investigational Phase 4 113-45-1 4158
35
Loxapine Approved Phase 4 1977-10-2 3964
36
Metformin Approved Phase 4 657-24-9 14219 4091
37
Epinephrine Approved, Vet_approved Phase 4 51-43-4 5816
38
Racepinephrine Approved Phase 4 329-65-7 838
39
Methylcobalamin Approved, Investigational Phase 4 13422-55-4
40
Hydroxocobalamin Approved Phase 4 13422-51-0 11953898 15589840
41
Amphetamine Approved, Illicit, Investigational Phase 4 300-62-9 5826 3007
42
Dextroamphetamine Approved, Illicit Phase 4 51-64-9 5826
43
Acetaminophen Approved Phase 4 103-90-2 1983
44
Bromocriptine Approved, Investigational Phase 4 25614-03-3 31101
45
Ondansetron Approved Phase 4 99614-02-5 4595
46
Simvastatin Approved Phase 4 79902-63-9 54454
47
Losartan Approved Phase 4 114798-26-4 3961
48
Angiotensin II Approved, Investigational Phase 4 68521-88-0, 4474-91-3, 11128-99-7 172198
49
Oxcarbazepine Approved Phase 4 28721-07-5 34312
50
Clozapine Approved Phase 4 5786-21-0 2818

Interventional clinical trials:

(show top 50) (show all 1485)
# Name Status NCT ID Phase Drugs
1 An Open Label, Multicenter, Single Arm, 4-Week Study to Evaluate the Efficacy and Safety of Flexible Dose of Quetiapine Fumarate (Seroquel) Switching From Other Drugs in the Treatment of Acute Manic Patients With Bipolar Disorder Unknown status NCT00837343 Phase 4 quetiapine fumarate tablet (Seroquel)
2 Effects of N-Acetyl-Cysteine on Oxidative Stress Biomarkers in Bipolar Patients With and Without Tobacco Use Disorder Unknown status NCT02252341 Phase 4
3 Neurofunctional and Neurochemical Markers of Treatment Response in Bipolar Disorder Unknown status NCT00608075 Phase 4 lithium;Lithium
4 Exploring Alterations of Central Autonomic Modulation in Patients With Bipolar Depression Unknown status NCT01213121 Phase 4 Quetiapine
5 A Randomized, Double-blind, Placebo-controlled Study of Quetiapine SR and Divalproex Sodium ER on Anxiety in Bipolar Disorder With at Least Moderately Severe Current Anxiety and Lifetime Panic or Generalized Anxiety Disorder. Unknown status NCT00579280 Phase 4 quetiapine SR;divalproex sodium ER;placebo
6 Assessing the Efficacy of Left Repetitive Transcranial Magnetic Stimulation (rTMS) as an Adjunctive Treatment to Mood Stabilizers for the Treatment of Bipolar Depression Unknown status NCT01583023 Phase 4 Bupropion
7 Assessment and Follow Up Study of Children and Adolescent With Bipolar Disorder Unknown status NCT01000402 Phase 4 Psychopharmacotherapy
8 A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar I and II Depression. Unknown status NCT00335205 Phase 4 ropinirole
9 Algorithm Guided Treatment Strategies for Bipolar Depression Unknown status NCT01938859 Phase 4 Lithium;Quetiapine;Shuganjieyu capsule
10 Clinical Psychopharmacology Division Institute of Mental Health, Peking University Unknown status NCT03148535 Phase 4 Lithium Carbonate;lithium carbonate combined with SSRI antidepressant treatment
11 A Randomized Open-label Active-controlled Study to Evaluate the Efficacy and Safety of Utapine Versus Seroquel in Patients With Bipolar Mania Unknown status NCT01043679 Phase 4 Utapine;Seroquel
12 Comparative Efficacy and Acceptability of Lithium, Valproate, Oxcarbazepine, Quetiapine, Olanzapine, and Ziprasidone in Bipolar I Disorder, Manic or Mixed Phase Unknown status NCT01893229 Phase 4 Lithium;Valproate;Oxcarbazepine;Quetiapine;Olanzapine;Ziprasidone
13 Open Label Prophylaxis Study of Lithium Plus Extended- Release Carbamazepine (Equetro®) Combination for Rapid Cycling Bipolar Disorder Unknown status NCT00325286 Phase 4 Lithium Plus Extended- Release Carbamazepine
14 Reduction of Cardiovascular Risk in Severe Mental Illness Prescribing and Using Better and More Appropriated Drugs Unknown status NCT01182012 Phase 4
15 Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia by Aripiprazole Add-on Therapy in the Treatment of Schizophrenia and Bipolar Disorder: An Open-Label Trial Unknown status NCT00541554 Phase 4 Abilify (aripiprazole)
16 Myoinositol for the Treatment of Ovarian and Psychiatric Disorder in PCOS Patients. Unknown status NCT01246310 Phase 4
17 Phase 3 Reboxetine Treatment in Depressed Children and Adolescents an 8-Week, Open Study Unknown status NCT00426946 Phase 4 Reboxetine
18 The Effect of Quetiapine XR in Depressive Patients Showing Aberrant N100 Amplitude Slope Unknown status NCT01357967 Phase 4 SSRI monotherapy;Seroquel XR adjunctive
19 A Randomized, Sham Controlled, Crossover Trial of rTMS for Bipolar Depression Completed NCT00186758 Phase 4
20 Comparison of Propofol Target-Controlled Infusion Anesthesia and Bolus Injection in Electroconvulsive Therapy: A Randomized Controlled Trial Completed NCT03863925 Phase 4
21 Lamictal for Use in Treatment of Bipolar Disorder In Adults. A Practical Clinical Assessment of Tolerability and Clinical Effectiveness. Completed NCT00067938 Phase 4 lamotrigine
22 A Multi-center, Randomized, Double-blind, Parallel Group, Placebo-controlled 52 Weeks Clinical Trial to Evaluate Efficacy and Safety of Oxcarbazepine p.o.(300-1200 mg/Day) as Adjuvant Therapy in the Bipolar Disorder I or II Treatment Completed NCT00154323 Phase 4 Oxcarbazepine
23 A Randomized, Open Label Trial of Olanzapine Versus Lithium in the Treatment of Acute Depression in Patients With Bipolar II or Bipolar Not Otherwise Specified. Completed NCT02287259 Phase 4 olanzapine;lithium
24 An Open-Label Extension Study to Assess the Safety of Lamotrigine in Subjects With Bipolar Disorder, Who Are in Remission Following a Manic/Hypomanic Index Episode or a Depressive Index Episode. Completed NCT00360126 Phase 4 lamotrigine
25 Lamictal As Add on Treatment in Mixed States of Bipolar Disorder Completed NCT00223509 Phase 4 Lamotrigine
26 Multi-center, Double-blind, Randomized, Comparative Phase 4 Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of Abilify and Depakote in 24-week Treatment of Mania in Patients With Bipolar Disorder Remitted After 6-week Treatment With Abilify and Depakote Completed NCT00545675 Phase 4 Abilify(aripiprazole);Depakote (divalproate)
27 Multi-center, Single Arm, Open Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of Abilify With Depakote in the 6-week Treatment of Acute Mania in Patients With Bipolar Disorder Completed NCT00545142 Phase 4 Abilify(Aripiprazole);Depakote(Divalproate)
28 A 52-week, Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder Completed NCT00139594 Phase 4 licarbazepine
29 Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I Disorder Completed NCT00050206 Phase 4 Olanzapine;Placebo
30 Aripiprazole in Late Life Bipolar Disorder Completed NCT00194038 Phase 4 Aripiprazole
31 Adjunctive Ziprasidone in Overweight and Obese Patients With Bipolar Disorder Completed NCT00472641 Phase 4 Ziprasidone/Geodon
32 Quetiapine for Bipolar Disorder and Alcohol Dependence Completed NCT00457197 Phase 4 Placebo;Quetiapine
33 A Randomized, Double-blind, Placebo-controlled Study of the Efficacy of Ropinirole in the Treatment of Depression in Bipolar Disorder Completed NCT00314821 Phase 4 ropinirole
34 A Randomized, Double-Blind, Placebo Controlled Study Of Quetiapine SR (QTP) As Adjunctive Treatment In Mixed States (MS) Of Bipolar Disorder Completed NCT01195363 Phase 4 quetiapine SR;quetiapine sr placebo
35 Cognitive Enhancement in Bipolar Disorder Completed NCT00597896 Phase 4 pramipexole
36 Memantine and Cognitive Dysfunction in Bipolar Disorder Completed NCT00586066 Phase 4 Memantine;Placebo
37 Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder, Manic or Mixed Completed NCT00034580 Phase 4 olanzapine;risperidone
38 Olanzapine Plus Carbamazepine Versus Carbamazepine Alone in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder Completed NCT00190892 Phase 4 olanzapine;carbamazepine
39 Olanzapine/Fluoxetine Combination Versus Lamotrigine in the Treatment of Bipolar I Depression Completed NCT00485771 Phase 4 Olanzapine;Fluoxetine;Lamotrigine
40 Gulf Evaluation of VAlproate (Depakine Chrono) in maNia Study Completed NCT00477373 Phase 4 depakine chrono
41 Adjunctive Topiramate for Treatment of Alcohol Dependence in Patients With Bipolar Disorder Completed NCT00572117 Phase 4 Topiramate
42 A Phase IV STudy of the Effectiveness of Quetiapine Extended Release 600mg Once a Day to Control the Symptoms of Manic Phase of Bipolar Disorder. Completed NCT00521365 Phase 4 Quetiapine 600mg
43 Tranylcypromine Treatment of Bipolar Depression Completed NCT01430455 Phase 4 Tranylcypromine
44 Depakote ER Therapy for Mania Comorbid With Substance Abuse Completed NCT00208195 Phase 4 Divalproex ER
45 A Double-Blind, Randomized, Placebo-Controlled Trial of Ramelteon for the Treatment of Insomnia and Mood Stability in Patients With Euthymic Bipolar Disorder. Completed NCT00552760 Phase 4 Ramelteon;Placebo
46 Olanzapine Versus Divalproex and Placebo in the Treatment of Mild to Moderate Mania Associated With Bipolar I Disorder Completed NCT00094549 Phase 4 olanzapine;divalproex sodium;placebo
47 A Phase 4 Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar Disorder Completed NCT00195845 Phase 4 Galantamine;Placebos
48 A Double Blind, Randomized, Placebo Controlled Trial of Aripiprazole Plus Valproate in the Short-Term and Long-Term Treatment of Bipolar Disorder Completed NCT00484471 Phase 4 aripiprazole;valproate;placebo
49 A Double-Blind, Placebo-Controlled Trial of Lamotrigine In Individuals With Bipolar Disorder and Comorbid Alcohol Dependence Completed NCT01015586 Phase 4 Lamotrigine;Placebo
50 Comparative Effectiveness of a Second Generation Antipsychotic Mood Stabilizer And a Classic Mood Stabilizer for Bipolar Disorder Completed NCT01331304 Phase 4 Lithium;Quetiapine

Search NIH Clinical Center for Major Affective Disorder 9

Inferred drug relations via UMLS 71 / NDF-RT 50 :


Carbamazepine
Clonazepam
Clozapine
CLOZAPINE (CARACO)
CLOZAPINE (CLOZARIL)
CLOZAPINE (IVAX)
CLOZAPINE (TEVA)
CLOZAPINE (VERSACLOZ)
Divalproex Sodium
Fazaclo
gabapentin
gabapentin enacarbil
lamotrigine
Lithium
Lithium Aspartate
Lithium Carbonate
lithium citrate
Mylan brand of clozapine
olanzapine
quetiapine
Quetiapine fumarate
Risperidone
Sodium Valproate
tiagabine
Tiagabine hydrochloride
topiramate
UDL brand of clozapine
Valproic Acid

Genetic Tests for Major Affective Disorder 9

Anatomical Context for Major Affective Disorder 9

MalaCards organs/tissues related to Major Affective Disorder 9:

40
Brain, Cortex, Testes, Prefrontal Cortex, Amygdala, Thyroid, Cingulate Cortex

Publications for Major Affective Disorder 9

Articles related to Major Affective Disorder 9:

(show top 50) (show all 25117)
# Title Authors PMID Year
1
Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. 61 56
18711365 2008
2
Training engagement, baseline cognitive functioning, and cognitive gains with computerized cognitive training: A cross-diagnostic study. 61
31832340 2020
3
Preliminary study of structural magnetic resonance imaging phenotypes related to genetic variation in Interleukin-1β rs16944 in adolescents with Bipolar Disorder. 61
31918351 2020
4
Elated or sad mood induction affects the attention of patients with a bipolar disorder less than that of patients with a depressive disorder. 61
31707921 2020
5
Comprehensive phenotyping of depression disease trajectory and risk: Rationale and design of Texas Resilience Against Depression study (T-RAD). 61
31918350 2020
6
Beliefs about the automaticity of positive mood regulation: examination of the BAMR-Positive Emotion Downregulation Scale in relation to emotion regulation strategies and mood symptoms. 61
31174453 2020
7
Efficacy of melatonin as an adjunct in the treatment of acute mania: a double-blind and placebo-controlled trial. 61
31743233 2020
8
Comorbid personality disorders in manic bipolar I disorder patients is associated with increased use of long-acting injectable antipsychotic treatment and higher rates of rehospitalization. 61
31764217 2020
9
Structural alterations associated with suicide attempts in major depressive disorder and bipolar disorder: A diffusion tensor imaging study. 61
31778758 2020
10
Mixed Features in Depression: The Unmet Needs of Diagnostic and Statistical Manual of Mental Disorders Fifth Edition. 61
32008688 2020
11
Pigment epithelium-derived factor alleviates depressive-like behaviors in mice by modulating adult hippocampal synaptic growth and Wnt pathway. 61
31676463 2020
12
Perinatal Mixed Affective State: Wherefore Art Thou? 61
32008678 2020
13
Diagnosis, Clinical Features, and Implications of Agitated Depression. 61
32008687 2020
14
The Ring of Fire: Childhood Trauma, Emotional Reactivity, and Mixed States in Mood Disorders. 61
32008689 2020
15
Mixed States in Early-Onset Bipolar Disorder. 61
32008691 2020
16
Positive and Negative Activation in the Mood Disorder Questionnaire: Associations With Psychopathology and Emotion Dysregulation in a Clinical Sample. 61
31137947 2020
17
Connectivity strength of the EEG functional network in schizophrenia and bipolar disorder. 61
31682892 2020
18
Mice lacking neuronal calcium sensor-1 show social and cognitive deficits. 61
31821787 2020
19
Drugs used to treat bipolar disorder act via microRNAs to regulate expression of genes involved in neurite outgrowth. 61
31913086 2020
20
Targeted sequencing of the LRRTM gene family in suicide attempters with bipolar disorder. 61
31854516 2020
21
Bipolar disorder with and without a history of psychotic features: fMRI correlates of sustained attention. 61
31756418 2020
22
Reward and punishment learning in schizophrenia and bipolar disorder. 61
31622639 2020
23
Lithium chloride promotes lipid accumulation through increased reactive oxygen species generation. 61
31676444 2020
24
Individual prediction of symptomatic converters in youth offspring of bipolar parents using proton magnetic resonance spectroscopy. 61
32008167 2020
25
Satisfaction and attitude of bipolar patients regarding electroconvulsive therapy: modified or unmodified. 61
31657256 2020
26
Corrigendum to ``Violent criminal behavior in the context of bipolar disorder: Systematic review and meta-analysis'' [Journal of Affective Disorders (2018) 239:161-170]. 61
31668994 2020
27
The causal relationships of device-measured physical activity with bipolar disorder and schizophrenia in adults: A 2-Sample mendelian randomization study. 61
31780129 2020
28
Subjective cognitive dysfunction in patients with bipolar disorder: The prevalence, related factors and effects on predicting psychosocial functioning and suicidal ideation. 61
31740217 2020
29
Use of a serious game to strengthen medication adherence in euthymic patients with bipolar disorder following a psychoeducational programme: A randomized controlled trial. 61
31668996 2020
30
Post-traumatic stress burden in a sample of hospitalized patients with Bipolar Disorder: Which impact on clinical correlates and suicidal risk? 61
31732278 2020
31
The effect of atorvastatin on cognition and mood in bipolar disorder and unipolar depression patients: A secondary analysis of a randomized controlled trial. 61
31733459 2020
32
Internalized stigmatization in borderline personality disorder and attention deficit hyperactivity disorder in comparison to bipolar disorder. 61
31733922 2020
33
Development of bipolar disorder and other comorbidity among youth with attention-deficit/hyperactivity disorder. 61
31523819 2020
34
A 50-Year-Old Woman With Confusion and Facial Rash. 61
32033659 2020
35
Identifying common genome-wide risk genes for major psychiatric traits. 61
31813014 2020
36
Orbitofrontal Sulcogyral Pattern as a Transdiagnostic Trait Marker of Early Neurodevelopment in the Social Brain. 61
32028799 2020
37
Comparing mental health disorders among sex trafficked children and three groups of youth at high-risk for trafficking: A dual retrospective cohort and scoping review. 61
31575432 2020
38
A systematic review of online interventions for families of patients with severe mental disorders. 61
31818771 2020
39
Unipolar mania: Identification and characterisation of cases in France and the United Kingdom. 61
31818781 2020
40
Cannabis use: A co-existing condition in first-episode bipolar mania patients. 61
31818791 2020
41
Cortico-limbic functional connectivity mediates the effect of early life stress on suicidality in bipolar depressed 5-HTTLPR*s carriers. 61
31969273 2020
42
Prediction of lithium response using clinical data. 61
31667829 2020
43
Executive functions and memory in bipolar disorders I and II: new insights from meta-analytic results. 61
31697843 2020
44
Emotion regulation as a transdiagnostic process. 61
31961175 2020
45
Real-time particle-by-particle detection of erythrocyte-camouflaged microsensor with extended circulation time in the bloodstream. 61
32019879 2020
46
Psychiatric diagnosis, gender, aggression, and mode of attempt in patients with single versus repeated suicide attempts. 61
31927168 2020
47
Protein intake is associated with cognitive functioning in individuals with psychiatric disorders. 61
31791705 2020
48
Focus on Causality in ESC/iPSC-Based Modeling of Psychiatric Disorders. 61
32033412 2020
49
A closer look at the nosological status of the highs (hypomanic symptoms) in the postpartum period. 61
32034530 2020
50
Vascular endothelial growth factor in bipolar depression: A potential biomarker for diagnosis and treatment outcome prediction. 61
31986357 2020

Variations for Major Affective Disorder 9

Expression for Major Affective Disorder 9

Search GEO for disease gene expression data for Major Affective Disorder 9.

Pathways for Major Affective Disorder 9

GO Terms for Major Affective Disorder 9

Sources for Major Affective Disorder 9

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....